z-logo
open-access-imgOpen Access
Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate
Author(s) -
Kristopher A. Lofgren,
Nicolette C. Reker,
Sreeja Sreekumar,
Paraic A. Kenny
Publication year - 2022
Publication title -
antibody therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.579
H-Index - 5
ISSN - 2516-4236
DOI - 10.1093/abt/tbac020
Subject(s) - amphiregulin , cancer research , epiregulin , monoclonal antibody , epidermal growth factor receptor , cancer , epidermal growth factor , antibody , conjugate , epitope , chemistry , biology , immunology , medicine , receptor , biochemistry , mathematical analysis , mathematics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom